Loading
Latest filing published 30 Dec 2020 for Oryzon Genomics, S.A., €930k.
No signal scores available.
One trade, one date: on 30 December 2020, Tamara Maes disclosed an open-market sale of €930k in Oryzon Genomics, S.A. No broader history exists yet. Source: insider filings from CNMV. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration